Showing 2191-2200 of 23139 results for "".
The Role of Presbyopia-Correcting Drops
https://reachmd.com/cme/ophthalmology/The-Role-of-Presbyopia-Correcting-Drops-2508/29737/Learn about miotics and how they work for presbyopia correction, especially for certain patients who are not ready for surgical options.When GDMT Isn’t Enough: Understanding Residual Risk in Patients with HFrEF
https://reachmd.com/programs/cme/when-gdmt-isnt-enough-understanding-residual-risk-in-patients-with-hfref/51036/Drs. Bauersachs, Butler & Lam discuss persistent residual risk in HFrEF, the use of sGC stimulators to reduce risk, and supporting evidence for this approach.Evidence at a Glance: The Totality of Evidence Impacting Clinical Decision-Making in Patients with HFrEF Without a Recent Worsening Event
https://reachmd.com/programs/cme/evidence-at-a-glance-the-totality-of-evidence-impacting-clinical-decision-making-in-patients-with-hfref-without-a-recent-worsening-event/54634/Drs. Bauersachs, Butler & Lam discuss persistent residual risk in HFrEF, the use of sGC stimulators to reduce risk, and supporting evidence for this approach.Safety, Clinical Integration, and the Emerging Fifth Pillar in HF Practice
https://reachmd.com/programs/cme/safety-clinical-integration-and-the-emerging-fifth-pillar-in-hf-practice/54635/Drs. Bauersachs, Butler & Lam discuss persistent residual risk in HFrEF, the use of sGC stimulators to reduce risk, and supporting evidence for this approach.Personalized Care in Atopic Dermatitis: Addressing Patient-Specific Factors
https://reachmd.com/programs/medical-industry-feature/personalized-care-in-atopic-dermatitis-addressing-patient-specific-factors/32931/Learn about how to combine systemic treatment options with patient preferences in atopic dermatitis care.Advances in Acne Care: Evaluating Adapalene-Clindamycin Gel
https://reachmd.com/programs/clinicians-roundtable/advances-in-acne-care-evaluating-adapalene-clindamycin-gel/30052/Find out how a fixed-dose combination gel for moderate facial acne may help combat challenges associated with standard monotherapies.Improving CKD Awareness: Emphasizing the Risk in Patients Who Are Unaware
https://reachmd.com/programs/clinicians-roundtable/improving-ckd-awareness-emphasizing-the-risk-in-patients-who-are-unaware/17942/Dive in to review some of the common misunderstandings and learn strategies for improvement associated with CKD among HCPs and patients.Toward a Healthier Journey for the Type 2 Diabetes Patient
https://reachmd.com/programs/diabetes-discourse/toward-a-healthier-journey-for-the-type-2-diabetes-patient/7585/Host Dr. John Russell welcomes Candis M. Morello, PharmD., CDE, FCSHP, Professor of Clinical Pharmacy and Associate Dean for Student Affairs at the Skaggs School of Pharmacy and Pharmaceutical Sciences. Dr. Morello explains the importance of patient education, communication, and motivation needed toNeurosurgical Quality Improvement Measures & Patients With Degenerative Disc Disease
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/neurosurgical-quality-improvement-measures-patients-with-degenerative-disc-disease/6533/How much do quality improvement efforts improve quality of life for neurosurgical patients? Host Dr. Lee Freedman talks to Dr. Neil Malhotra, assistant professor of neurosurgery at the University of Pennsylvania and the Penn Neurological Institute of the Pennsylvania Hospital, about new efforts to iAdvances in IgAN: New Frontiers in Biomarkers and Treatment
https://reachmd.com/programs/frontlines-iga-nephropathy/advances-in-igan-new-frontiers-in-biomarkers-and-treatment/26944/How can understanding the pathogenesis of IgA nephropathy lead to targeted therapies that slow disease progression? Tune in to find out.